胰腺癌新兴嵌合抗原受体免疫细胞治疗:机制、临床进展与未来展望
Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives.
49.6分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives.
共 1 条
MEMBER ACCOUNT
登录成功会直接打开下一页。